Skip to main content

Table 4 Clinicopathological characteristics of the 423 PTC

From: Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer

Variables

PTCs with low glycolysis signature

PTCs with high glycolysis signature

χ2* or t† or H.R.§/ p-value

Gender (M:F)

59:153

50:161

0.74*/0.389

Age (years)

43 (15–89)

47 (19–83)

3.06†/0.002

Stage

 1 / 2 / 3 / 4

131 / 15 / 45 / 20

119 / 23 / 48 / 20

0.995‡

 Recurrence-free survival time (months)

14.59 (0–158.71)

14.06 (0–157.03)

1.50§/0.033

  1. ‡ p-value from Analysis of Variance
  2. PTC Papillary Thyroid Cancer; H.R Hazard Ratio
  3. Data in parentheses are ranges